Literature DB >> 8703581

Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect.

M D Grynpas1, E Hamilton, R Cheung, Y Tsouderos, P Deloffre, M Hott, P J Marie.   

Abstract

Low doses of strontium and fluoride were shown to increase bone formation and trabecular bone density in rodents. To assess whether strontium or fluoride affect the quality of the mineral at doses known to increase bone density, we have determined the effects of low doses of strontium and fluoride on bone formation and bone mineral characteristics in rats. Adult rats were given strontium alone (0.20%), fluoride alone (1 mg/kg per day), or the combined treatment for 8 weeks. Strontium levels in serum and femur were similar in groups treated with strontium alone or in combination, being about 5% of calcium levels. Biochemical and neutron activation analyses in femur showed that calcium and magnesium contents did not differ in the four group of rats, suggesting that strontium was incorporated in the apatite lattice of the bone minerals in the strontium-treated rats. The mineralized bone volume was significantly increased by 17% in the strontium-treated group, by 20% in the fluoride-treated group, and by 19% in rats given with the combined treatment. This was associated with increased osteoid surface, osteoblast surface, and double tetracycline labeled surfaces in the strontium-treated and fluoride-treated groups, showing that the number of bone forming sites was increased. However, the mineral apposition rate, the osteoid thickness, and the mineralization lag time were similar in controls and treated groups, reflecting the lack of deleterious effects of low doses of strontium and fluoride on bone mineralization. The density fractionation analysis measured in the femur also showed that neither strontium, nor fluoride at the low doses used, significantly altered the mineralization profile. The results indicate that treatment with low doses of strontium or fluoride increase the number of bone forming sites and vertebral bone volume in rats, but does not have detectable adverse effects on the mineral profile, bone mineral chemistry or bone matrix mineralization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703581     DOI: 10.1016/8756-3282(95)00484-x

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  21 in total

Review 1.  Is the calcium receptor a molecular target for the actions of strontium on bone?

Authors:  Edward M Brown
Journal:  Osteoporos Int       Date:  2003-03-12       Impact factor: 4.507

2.  Dietary strontium increases bone mineral density in intact zebrafish (Danio rerio): a potential model system for bone research.

Authors:  Anthony J Siccardi; Steve Padgett-Vasquez; Heath W Garris; Tim R Nagy; Louis R D'Abramo; Stephen A Watts
Journal:  Zebrafish       Date:  2010-09       Impact factor: 1.985

3.  Microarchitecture and nanomechanical properties of trabecular bone after strontium administration in osteoporotic goats.

Authors:  Zhaoyang Li; Songlin Peng; Haobo Pan; Bin Tang; Raymond W M Lam; William W Lu
Journal:  Biol Trace Elem Res       Date:  2011-08-04       Impact factor: 3.738

4.  Osteoporosis and strontium-substituted hydroxyapatites.

Authors:  Nikolaos Kourkoumelis
Journal:  Ann Transl Med       Date:  2016-10

5.  A physiologically based pharmacokinetic model for strontium exposure in rat.

Authors:  Henry Pertinez; Marylore Chenel; Leon Aarons
Journal:  Pharm Res       Date:  2013-03-30       Impact factor: 4.200

6.  Study of the reactivity and in vitro bioactivity of Sr-substituted alpha-TCP cements.

Authors:  S Jegou Saint-Jean; C L Camiré; P Nevsten; S Hansen; M P Ginebra
Journal:  J Mater Sci Mater Med       Date:  2005-11       Impact factor: 3.896

Review 7.  Strontium ranelate: a novel mode of action leading to renewed bone quality.

Authors:  Patrick Ammann
Journal:  Osteoporos Int       Date:  2005-01       Impact factor: 4.507

8.  Controlling the strontium-doping in calcium phosphate microcapsules through yeast-regulated biomimetic mineralization.

Authors:  Miaojun Huang; Tianjie Li; Ting Pan; Naru Zhao; Yongchang Yao; Zhichen Zhai; Jiaan Zhou; Chang Du; Yingjun Wang
Journal:  Regen Biomater       Date:  2016-07-31

9.  Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants.

Authors:  S D Bain; C Jerome; V Shen; I Dupin-Roger; P Ammann
Journal:  Osteoporos Int       Date:  2008-12-19       Impact factor: 4.507

10.  Injectability of brushite-forming Mg-substituted and Sr-substituted alpha-TCP bone cements.

Authors:  S Pina; P M C Torres; J M F Ferreira
Journal:  J Mater Sci Mater Med       Date:  2009-10-23       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.